Delivery Order SPE2DB20D3104-SPE2DB24FV8W5

Award Date 8/19/24
Potential Completion Date 8/20/24
Potential Value $2.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,664.84, is for the delivery of Timolol Maleate 0.5% eye drops in 60 count unit dose packaging. The contract is a Firm Fixed Price Delivery Order, with a completion date of November 13, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award is for the delivery of Timolol 0.5% gel-solution, a pharmaceutical eye drop product, to the Defense Logistics Agency (DLA). The $1,484.66 firm-fixed-price delivery order was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00. This IDC serves as the primary vehicle for Amerisourcebergen to provide a wide range of pharmaceutical products...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,951.77 firm fixed-price delivery order is for the supply of Timolol 0.5% gel-solution, a medication used to treat certain eye conditions. The contract has an ultimate completion date of December 6, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $1,362.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of Timolol 0.5% Gel-Solution, a prescription eye drop, to support military healthcare programs. The contract has an ultimate completion date of November 6, 2024 and is a firm fixed-price arrangement. It is not designated as a set-aside contract,...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Timolol Maleate 0.5% eye drops in unit dose 60s packaging. The firm-fixed-price delivery order, valued at $1,173.52, has an ultimate completion date of January 25, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,594.28 firm fixed-price delivery order is for the provision of 4565243277 - Dorzolamide-Timolol eye drops, 10 mL. The contract has an ultimate completion date of July 25, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,309.28 firm fixed-price delivery order is for the supply of Timolol 0.5% Gel-Solution, a medication used for the treatment of eye conditions. The contract has a period of performance through January 31, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Timolol 0.5% gel-solution, a prescription eye drop medication. The $2,362.48 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to...
This is a federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $1,393.48, is for the delivery of Timolol Maleate 0.5% eye drops in 60-count units. This is a Firm Fixed Price Delivery Order contract with an ultimate completion date of November 15, 2024. The contract is not designated with a set-aside. AmerisourceBergen holds a significant Indefinite...
This federal contract award is for the delivery of Timolol 0.5% gel-solution, a pharmaceutical eye drop medication, to the Defense Logistics Agency (DLA). The $1,381.37 firm fixed-price delivery order was issued to the prime contractor, AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves...
  • SPE2DB20D3104
    Indefinite Delivery Contract
  • SPE2DB20D3104-SPE2DB24FV8W5
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,165.76, is a Firm Fixed Price Delivery Order contract for the supply of Timolol 0.5% eye drops (5 ml). The contract has an ultimate completion date of August 20, 2024 and is not associated with any set-aside designation, indicating open competition.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 2/27/25, 10:31 AM